Lesions that were detectable on DWI-MRI but did not show tracer uptake on concurrent PSMA-PET, but had shown focal tracer accumulation on previous PSMA-PET prior to cancer treatment, were considered nonviable, i.e., showing treatment response. The gene discussed is FOLH1; the disease is cancer.